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ABSTRACT
Defects in DNA replication and repair are known
to promote genomic instability, a hallmark of can-
cer cells. Thus, eukaryotic cells have developed
complex mechanisms to ensure accurate duplica-
tion of their genomes. While DNA damage response
has been extensively studied in tumour cells, the
pathways implicated in the response to replica-
tion stress are less well understood especially in
non-transformed cells. Here we show that in non-
transformed cells, APC/CCdh1 is activated upon se-
vere replication stress. Activation of APC/CCdh1 pre-
vents new origin firing and induces permanent ar-
rest in S-phase. Moreover, Rad51-mediated homol-
ogous recombination is also impaired under these
conditions. APC/CCdh1 activation in S-phase occurs
after replication forks have been processed into dou-
ble strand breaks. Remarkably, this activation, which
correlates with decreased Emi1 levels, is not pre-
vented by ATR/ATM inhibition, but it is abrogated in
cells depleted of p53 or p21. Importantly, we found
that the lack of APC/CCdh1 activity correlated with an
increase in genomic instability. Taken together, our
results define a new APC/CCdh1 function that pre-
vents cell cycle resumption after prolonged replica-
tion stress by inhibiting origin firing, which may act
as an additional mechanism in safeguarding genome
integrity.
INTRODUCTION
Faithful DNA replication is essential to prevent DNA dam-
age and chromosomal instability, a hallmark of cancer
(1). Replication errors induced by natural replication fork
barriers such as secondary DNA structures, non-histone
protein/DNA interactions and replication-transcription
clashes, as well as replication stress induced by nucleotide
deficiency (2) and DNA damage underlie many genome al-
terations that can compromise genome integrity (3–7). In-
terestingly, during recent years compelling evidences have
arisen indicating that oncogene overexpression in non-
transformed cells causes replication stress, inducing DNA
damage and a permanent withdrawal from the cell cy-
cle (8,9). This process, known as oncogene-induced senes-
cence (OIS), is considered a tumourigenic barrier. Thus,
an accurate knowledge of the DNA replication stress re-
sponse in non-transformed cells is important to understand
the alterations that allow OIS bypass in tumour cells, as
well as to develop new cancer therapies to act specifically
against transformed cells. In this regard, taking advantage
of the fact that tumour cells have increased DNA replica-
tion stress, it has been proposed that novel therapeutic ap-
proaches could be developed that capitalize on the presence
of DNA replication stress in cancer but not normal cells
(10).
Arrested replication forks and DNA double strand
breaks (DSBs) in S-phase are signalled by distinct pathways
known as the DNA replication checkpoint and the DNA
damage checkpoint respectively.Once activated, these intra-
S-phase checkpoints promote replication fork stabilization
and DNA repair, regulate cell cycle progression and, even-
tually, control the resumption of DNA replication, ensur-
ing correct genome duplication (3). In mammalian cells the
central players of the DNA replication checkpoint path-
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way are ATR and Chk1 kinases. Notably, ATR and Chk1
are also essential for correct DNA replication during nor-
mal cell cycle progression by controlling both replication
fork stability and origin firing (11–15). Upon stalling of
replication forks, Replication Protein A (RPA)-coated re-
gions of single-stranded DNA are generated, which medi-
ate the recruitment of ATR and a subset of proteins essen-
tial for its activation (16). Once activated, ATR, in com-
plex with Claspin, phosphorylates and activates Chk1 (17).
Chk1 arrests cell cycle progression and mitotic entry by
down-regulation of Cdk2/Cyclin A and Cdk1/Cyclin B
activities through inhibition of several isoforms of Cdc25
phosphatases (18–21) and activation of the tyrosine ki-
nase Wee1 (22), these being positive and negative regula-
tors of the Cdk/cyclin complexes respectively. In addition,
ATR/Chk1 inhibits late origin firing after DNA replica-
tion stress while allowing activation of nearby dormant ori-
gins (23), which is important for correct global replication
restart under these conditions (24). Moreover, Chk1 pro-
motes Treslin phosphorylation, thus preventing loading of
replication initiation protein Cdc45 to the origins (13). An-
other critical role for ATR and Chk1 in response to repli-
cation stress is the stabilization of replication forks, which
prevents generation of additional DNA damage and al-
lows faithful replication restart (25). Specifically, Chk1 pre-
vents Mus81/Eme1 endonuclease-dependent DSB forma-
tion at the replication forks (14). However, stalled forks
can eventually collapse and be processed into DSBs after
prolonged replication arrest (26). In this regard, Helledays’
group showed that after a short (2 h) hydroxyurea (HU)
treatment, U2OS (osteosarcoma) cells were able to restart
DNA synthesis by reactivating stalled forks, while after a
long period of HU treatment (24 h), forks were converted
into DSBs and replication was reinitiated mainly by new
origin activation. It should be noted that even thoughDNA
synthesis could be completed by new origin firing, DSBs
originated at collapsed forks would need to be repaired.
Nevertheless, the reactivation of forks that have been pro-
cessed into DSBs can also be achieved by a sub-pathway
of homologous recombination (HR) called break-induced
replication (BIR) (27–30). In response to DSBs, Mre11-
Rad50-Nbs1 (MRN) complex binds to DNA and together
with other helicases and nucleases such as BLM,CtIP, Exo1
and Dna2 creates a 3′ single-stranded DNA overhang that
it is ultimately coated by Rad51, which promotes homol-
ogy search and strand invasion, both essential steps in HR
repair (31). While replication resumption can be achieved
by error-free mechanisms before DSBs are present, once
damaged, replication fork restart can disrupt genome in-
tegrity as BIR-mediated restart of damaged forks is highly
mutagenic. Indeed, BIR-based mechanisms can explain the
complexity of the chromosomal changes that occur in can-
cer cells (4,28,32–34). Moreover, HR in S-phase can re-
sult in epigenetic alterations (35). Additionally, altering the
timing of origin activation also induces changes in epige-
netic marks (36,37). Thus, restarting DNA replication after
DSB formation could induce genomic instability and alter-
ations in epigenetic determinants, favouring tumour forma-
tion and progression. Data showing that an extra allele of
Chk1 limits oncogene-induced replication stress and pro-
motes transformation (38) reflects the relevance of directing
non-transformed cells to senescence instead of promoting
potential error-prone repair of replication stress-induced
DNA damage in order to avoid transformation.
Several studies have focused on understanding the mech-
anisms controlling senescence after DNA damage. Inter-
estingly, it has recently been proposed that DNA damage-
activated senescence is mainly induced in G2-phase (39).
In G2, DSBs induce permanent cell cycle exit mediated by
p53 and p21 (40). This cell cycle exit is rapidly determined,
with p21-mediated nuclear Cyclin B1 translocation being
the first detectable event of this decision, which is followed
by Cdh1-bound anaphase-promoting complex/cyclosome
(APC/CCdh1)-mediated Cyclin B1 degradation (41–43).
Several studies have also reported unscheduled APC/CCdh1
activation in G2 upon DNA damage (44–46). APC/C is an
E3 ubiquitin ligase that is involved in cell cycle regulation
and becomes activated upon sequential binding of Cdc20
and Cdh1 coactivators (47,48). Cdc20 is associated with
APC/C during early mitosis and mainly regulates mitotic
progression, whereas Cdh1 interacts with APC/C from late
mitosis onwards until the followingG1/S transition (47,49).
During S- and G2-phases, APC/C is kept inactive through
different mechanisms: Cdk2/Cyclin A- and Cdk1/Cyclin
A-mediated phosphorylation of Cdh1, which hinder associ-
ation of Cdh1 with APC/C (49–52), Emi1-mediated disrup-
tion of APC/CCdh1 and APC/CCdc20 interaction with their
substrates (50,53) and degradation of bothCdh1 andUbc10
(a ubiquitin-conjugating enzyme that works with APC/C)
(54). In response to DNA damage, the unscheduled activa-
tion of this ubiquitin ligase has been proposed to depend on
either Emi1 down-regulation or Cdc14B phosphatase acti-
vation (45,46,55,56).
As mentioned above, the mechanisms leading to cell cy-
cle withdrawal after DNA damage in G1 and G2 have
been broadly studied. However, although irreversible arrest
upon prolonged replication inhibition has been described
in different cell lines (57), the circumstances and pathways
leading to permanent cell cycle arrest in response to DNA
replication stress in non-transformed human cells remain
to be elucidated. In the current study, we have analysed
the response of non-transformed human cells to HU or
to DNA damage induced during S-phase. Our data shows
that upon severe replication stress, the resumption of DNA
replication andmitotic entry are both compromised in non-
transformed cells, and that cells undergo senescence even
with unreplicated DNA. This loss of ability to resume repli-
cation is due to APC/CCdh1 activation in S-phase, which
causes new origin firing inhibition. Importantly, activation
of this ubiquitin ligase is observed after stalled replication
forks have collapsed and been processed into DSBs. Thus,
our results show for the first time that APC/CCdh1 is acti-
vated after severe replication stress to inhibit new origin fir-
ing, consequently preventing cell cycle progression of non-
transformed cells with damaged DNA.
MATERIALS AND METHODS
Cell culture, synchronization and drugs
hTERT-immortalized retinal pigment epithelial (hTERT-
RPE) cells, humanmammary epithelial MCF10A cells, col-
orectal cancer HCT116 cells and colorectal cancer DLD1
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cells were grown in DMEM: Ham’s F12 (1:1) medium
(Biological Industries) supplemented with 6% fetal bovine
serum (FBS, Biological Industries), except from MCF10A
cells that were supplemented with 5% horse serum (In-
vitrogen), 20 ng/ml epidermal growth factor (Peprotech),
0.5 g/ml hydrocortisone (Sigma-Aldrich) and 10 g/ml
insulin (Sigma-Aldrich). hTERT-immortalized foreskin BJ-
5ta fibroblasts were cultured in DMEM: M199 (4:1)
medium (from Biological Industries and Sigma-Aldrich re-
spectively) supplemented with 10% FBS. Human foreskin
1306 fibroblasts and human embryonic foreskin WS1 fi-
broblasts were cultured in MEM (Biological Industries)
medium supplemented with 10% FBS. Human cervical ep-
ithelial cancer HeLa cells, lung primary fibroblasts, squa-
mous cancer A431 cells, pancreatic cancer HPAFII cells,
colorectal cancer HT29 cells, breast cancer MCF7 cells,
pancreatic cancer SW1990 cells and osteosarcoma U2OS
cells were cultured in DMEM medium supplemented with
10% FBS. Peripheral blood lymphocytes were cultured in
RPMI (Biological Industries) medium 10% FBS. All cul-
turemediawere supplementedwith 1%non-essential amino
acids (Biological Industries), 2 mM L-glutamine (Sigma-
Aldrich), 1 mM pyruvic acid (Sigma-Aldrich), 50 U/ml
penicillin and 50 g/ml streptomycin (both from Biologi-
cal Industries).
For hTERT-RPE cells synchronization in S-phase by
serum starvation, cells were first grown in FBS-containing
medium until they reached full confluence. Cells were then
plated diluted (1/4) in culture medium without serum dur-
ing 48 h. After serum starvation cells were cultured again
in FBS-containing medium during 16 h. In order to syn-
chronize the different cell lines in S-phase by single thymi-
dine (Sigma-Aldrich) block, cells were plated during 12 h
(siRNA transfected cells) or 24 h in FBS-containing media
(if not specified otherwise). Thymidine was added (1.5 mM
to hTERT-RPE cells and 2.5 mM to the rest of cell lines)
during 22 h after which cells were extensively washed with
phosphate buffered saline (PBS) and released into fresh
medium without thymidine during 2 h.
Drugs and their working concentrations were used as fol-
lows: 10 M BrdU (Sigma-Aldrich), 50 M EdU (Invitro-
gen), 25 M CldU (Sigma-Aldrich) if not specified other-
wise, 250 M IdU (Sigma-Aldrich), 300 nMUCN-01 (Cal-
biochem, Merck KGaA), 10 M SB203580 (Calbiochem,
Merck KGaA), 20 M MG132 (Selleckchem), 10 M VE
821 (Axon Medchem), 100 nM CHIR-124 (Axon Med-
chem), 20 MKU-55933 (Selleckchem), 50 MproTAME
(BostonBiochem), 10 mMHU (Sigma-Aldrich) if not spec-
ified otherwise, nocodazole (Sigma-Aldrich) (50 ng/ml for
BJ-5ta and 250 ng/ml for the rest of the cell lines). Camp-
tothecin (Sigma-Aldrich) and etoposide (Sigma-Aldrich)
concentrations are indicated in the corresponding figure
legend.
Flow cytometry
Cells were harvested and fixed in 70% ethanol for at least 2 h
at−20◦Cbefore immunostaining and flow cytometry analy-
sis. Combined analysis of DNA content (1% propidium Io-
dide, PI, Sigma-Aldrich) and Phospho-H3 (anti-P-H3 S10,
Millipore, #06–570; 1/400) or DNA content, BrdU (anti-
BrdU, Abcam, ab6326; 1/250) and MPM2 (anti-MPM2,
Millipore, #05–368; 1/250) was performed as previously de-
scribed (58).
Colony formation and proliferation assays
For colony formation assays, hTERT-RPE and HCT116
cells were cultured in 12-well plates, synchronized by sin-
gle thymidine block in S-phase and then treated during 14
h with HU or left untreated. Cells were then extensively
washedwith PBS and then released into freshmediumwith-
out HU. After 12 h of release cells were plated diluted (250
cells in each well) in 6-well plates. Eight days later cells were
fixed and stained with 1% crystal violet in 70% ethanol dur-
ing 10 min at room temperature (RT) and the number of
colonies was counted.
For proliferation assays, hTERT-RPE cells were plated
in 12-well plates, synchronized in S-phase by single thymi-
dine block and then treated during 14 h with HU or left un-
treated. Cells were then extensively washed with PBS and
released into fresh medium without HU. Plates were har-
vested before the treatment, just after the treatment (0 h)
and at the indicated time after release. Finally, cells were
fixed in 4% paraformaldehyde- (PFA) PBS for 15 min at RT
and stained with 0.25% crystal violet during 5 min. Cristal
violet absorbance (595) was used to determine cell conflu-
ence in each condition.
Senescence-associated -Galactosidase (SA--Gal) assay
SA--Gal staining was performed as described previ-
ously (59). Briefly, cells were fixed in 2% PFA-/0.2%
glutaraldehyde-PBS for 3 min at RT and then incubated
with X-gal (B4252, Sigma) containing solution for 15 h at
37◦C in darkness. Images were obtained with Leica DMRB
microscope.
RNA interference
Transient siRNA experiments were performed using
HiPerfect Transfection Reagent (Qiagen). The following
siRNA oligos were transfected at 50 nM final con-
centration using manufacturer’s guidelines: (i) Human
ON-TARGETplus SMARTpool siRNA oligos that
specifically target Cdh1 (Dharmacon, L-015377-00-0005).
The siRNA oligo set contains four sequences as fol-
lows: Cdh1 #6: 5′-CCACAGGAUUAACGAGAAU-3′,
Cdh1 #7: 5′-GGAACACGCUGACAGGACA-3′, Cdh1
#8: 5′-GCAACGAUGUGUCUCCCU A-3′ and Cdh1
#9: 5′-GAAGAAGGGUCUGUUCACG-3′. (ii) Hu-
man ON-TARGETplus SMARTpool siRNA oligos
that specifically target p21 (Dharmacon, L-003471-00-
0005). The siRNA oligo set contains four sequences
as follows: 5′-CGACUGUGAUGCGCUAAUG-3′,
5′-CCUAAUCCGCCCACAGGAA-3′,
5′-CGUCAGAACCCAUGCGGCA-3′ and
5′-AGACCAGCAUGACAGAUUU-3′. (iii) Human
ON-TARGETplus SMARTpool siRNA oligos that
specifically target p53 (Dharmacon, L-003329-00-
0005). The siRNA oligo set contains four sequences
as follows: 5′-GAAAUUUGCGUGUGGAGUA-3′,
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5′-GUGCAGCUGUGGGUUGAUU-3′,
5′-GCAGUCAGAUCCUAGCGUC-3′ and
5′-GGAGAAUAUUUCACCCUUC-3′. (iv) Human
ON-TARGETplus SMARTpool siRNA oligos that
specifically target Emi1 (Dharmacon L-012434-00-
0005), The siRNA oligo set contains four sequences
as follows: 5′-CAACAGACACUUAAUAGUA-3′,
5′-CGAAGUGUCUCUGUAAUUA-3′,
5′-UGUAUUGGGUCACCGAUUG-3′ and
5′-GAAUUUCGGUGACAGUCUA-3′. (v) Human
ON-TARGETplus non-targeting pool (Dharma-
con, D-001810-10-20) was used as a negative con-
trol. The siRNA oligo set contains four sequences
as follows: 5′-UGGUUUACAUGUCGACUAA-3′,
5′-UGGUUUACAUGUUGUGUGA-3′,
5′-UGGUUUACAUGUUUUCUGA-3′ and
5′-UGGUUUACAUGUUUUCCUA-3′.
Immunoblotting
Cells were collected in 2% SDS containing 67 mM Tris-
HCl (pH 6.8) buffer, run in Laemmli SDS-polyacrylamide
gels and transferred to nitrocellulose membranes as previ-
ously described (58). Incubation with primary antibodies
was conducted overnight at 4◦C. Antibodies against the in-
dicated proteins were used as follows: Cyclin B1 (GNS1, sc-
245; 1/200), Cyclin A2 (H-432, sc-751; 1/500), Plk1 (F-8,
sc-17783; 1/50), Aurora A (Cell signalling, #3092; 1/500),
pRb (IF-8, sc-102; 1/500), p21 (Ab-1, OP64; 1/1000), Cdh1
(homemade against amino acids 1–225 of human Cdh1;
1/1000), p53 (Ab-5, MS-186; 1/1000), P-Chk1 S296 (Cell
signalling, #2349; 1/1000), P-Chk1 S345 (Cell signalling,
#2341; 1/1000), CtIP (A300–488A; 1/1000), P-Chk2 T68
(NB100-92502; 1/1000), Emi1 (37–6600; 1/100), Rad51
(H-92, sc-8349; 1/200), GAP120 (sc-63; 1/100), Cdk4 (H-
303, sc-749; 1/500), Lamin B (M-20; sc-6217; 1/200), actin
(Cell signalling, #69100; 1/5000) and H3 (Abcam, ab1791;
1/2000). Proteins were visualized using ECL detection sys-
tem (Biological Industries).
Chromatin enriched fraction isolation
For chromatin enriched fraction isolation, we followed a
protocol adapted from (60). Shortly, whole cell pellets were
incubated with 0.1% triton X-100 containing buffer A (10
mM HEPES (pH 7.4), 10 mM KCl, 1.5 mM MgCl2, 0.34
M sucrose, 10% glycerol) supplemented with protease and
phosphatase inhibitors for 20 min on ice. After buffer re-
moval by centrifugation (600 x g 4 min 4◦C) pellets were
rinsed with buffer A without triton and then incubated with
buffer B (3 mMEDTA, 0.2 mMEGTA) once again supple-
mented with inhibitors for 10 min on ice. After buffer re-
moval (1700 x g 5 min 4◦C) pellets were washed with buffer
B (600 x g 5 min 4◦C) and then resuspended in 2% SDS
containing 67 mMTris-HCl (pH 6.8) buffer. Chromatin en-
riched fractions were finally resuspended in Laemmli buffer
and analysed by immunoblotting as previously described.
Isolation of proteins on nascent DNA (iPOND)
Isolation of proteins on nascent DNA was performed as
described previously (61) with a few modifications. Briefly,
EdU-labelled and treated cells were fixed in 1% PFA for 10
min at RT and quenched with 0.125 mM glycine (pH 7) for
5 min at RT. Cells were harvested, pelleted by centrifuga-
tion and lysed in lysis buffer (ChIP Express kit, Active Mo-
tif) for 30 min at 4◦C. Lysates were passed 10× through a
21-gauge needle, and the nuclei were pelleted by centrifu-
gation and rinsed with PBS supplemented with protease in-
hibitor cocktail (PIC, Roche) before subject them to click
reaction for 30 min at RT with 0.2 mM Biotin-azide (In-
vitrogen). After click reaction, nuclei were pelleted by cen-
trifugation, rinsed with PBS + PIC, resuspended in shear-
ing buffer (ChIP Express kit, Active Motif) and sonicated
(Bioruptor, Diagenode) for 15 min at high intensity (30-
s/30-s on/off pulses). Streptavidin-conjugated Dynabeads
M-280 (Invitrogen) were washed three times with 1x block-
ing buffer (1% Triton X-100, 2 mMEDTA (pH 8), 150 mM
NaCl, 20 mM Tris-HCl (pH 8), 20 mM beta-glycerol phos-
phate, 2 mM sodium orthovanadate, PIC) and then blocked
for 1 h at RT with blocking buffer containing 10 mg/ml
salmon-spermDNA (Sigma-Aldrich). Lysates were then in-
cubated with previously blocked Dynabeads (1:10) for 30
min at RT. Finally, beads were washed twice with low-salt
buffer (containing 150 mM NaCl) and twice with high-salt
buffer (containing 500 mM NaCl), and then resuspended
in Laemmli buffer to analyse them by immunoblotting as
previously described.
Immunofluorescence microscopy
For immunofluorescence microscopy cells were grown on
glass coverslips and then treated as indicated. After treat-
ment, cells were rinsed with PBS and fixed in 2% PFA-PBS
for 20 min at RT. After extensive washing, cells were per-
meabilized with 0.2% Triton X-100 in PBS for 10 min at RT
and washed with PBS during 5min. Cells were then blocked
with 3% FBS containing 0.1% Triton X-100-PBS for 1 h
at RT and then incubated with the indicated antibodies di-
luted in blocking solution during 45 min at 37◦C. The fol-
lowing primary antibodies were used: anti-  -H2AX (Mil-
lipore, #05-636; 1/3000), anti-53BP1 (Abcam, ab36823;
1/500), anti-Cyclin D1 (DCS-6, sc-20044; 1/100). After ex-
tensive washing in blocking solution cells were stained with
Alexa488-, Alexa555- or Alexa647-conjugated secondary
antibodies (Invitrogen, 1/500 diluted in blocking solution)
for 20 min at 37◦C. Finally, cells were counterstained ei-
ther with 1% PI-containing 0.1 mg/ml RNAse A (Fermen-
tas) -PBS solution or with DAPI (Sigma-Aldrich). Images
were obtained using Leica TCS-SL confocal microscopy
and then analysed using Fiji software.
For EdU staining, previously labelled and treated cells
were fixed in 4% PFA-PBS for 30 min at RT and then click
reaction was performed (as previously described) for 30min
at RT with 1 M Alexa488-azide (Invitrogen) before im-
munostaining.
For CldU and IdU immunofluorescence analysis, previ-
ously labelled and treated cells were fixed for 10 min in 70%
ethanol at RT. Cells were then rinsed with PBS and incu-
bated with 0.2% triton X-100 containing 2 M HCl solution
for 30 min at RT. HCl was neutralized by washing three
times with borate buffer. Cells were then washed twice with
PBS and blocked with 1% bovine serum albumin- (BSA,
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Sigma-Aldrich) PBS. Finally, cells were incubated with pri-
mary anti-BrdU (Abcam, ab6326; 1/250 for CldU labelling
and Becton Dickinson, 347580; 1/50 for IdU labelling) and
secondary, anti-rat (Alexa488 conjugated; 1/500) and anti-
mouse (Alexa647 conjugated; 1/500) antibodies diluted in
blocking buffer. DNA was counterstained with DAPI.
Pulse field gel electrophoresis (PFGE)
For DNA break analysis cells were washed with PBS,
trypsinized and resuspended at 8.33× 106 cells/ml cell den-
sity in incubation buffer (0.25 mMEDTA, 20mMNaCl, 10
mM Tris, pH 7.5). This suspension (120 l) was mixed 1:1
with 1% low-melting point agarose (Sigma) to obtain two
agarose inserts each of them containing 0.5 × 106 cells. Af-
terwards, cells in plugs were lysed (0.25 mMEDTA, 20 mM
NaCl, 10 mM Tris, pH 7.5, 1% N-laurylsarcosyl, 1 mg/ml
proteinase K) for 48 h at 50◦C, washed three times with TE
buffer (10 mM Tris, 1 mM EDTA, pH 7.5) and run in 1%
agarose gel (chromosomal grade; Bio-Rad) in a CHEF DR
III PFGE apparatus (Bio-Rad; 120 angle; 60–240 s switch
time; 4 V/cm) at 14◦C for 20 h. Finally, gels were stained
with SYBRR© Safe and analysed using LAS-4000 system
(Fujifilm).
DNA fibre assay
DNA fibre assay was performed as previously described in
(26) with a few modifications. Briefly, hTERT-RPE cells
were pulse-labelled with CldU/IdU and treated as indi-
cated. Labelled cells were harvested by trypsinization and
resuspended in ice-cold PBS at 5 × 105 cells/ml. For DNA
spreading, 2 l of cells were spotted onto glass slides and
lysed with 7 l of spreading buffer (0.5% SDS, 200 mM
Tris-HCl (pH 7.4), 50 mMEDTA). Slides were tilted (15◦ to
horizontal), allowing a stream of DNA to run slowly down
the slide, air dried and then fixed in methanol/acetic acid
(3:1) solution. CldU and IdU were detected by incubating
acid-treated fibre spreads with anti-BrdU monoclonal an-
tibodies (Abcam, ab6326; 1/1000 for CldU labelling and
Becton Dickinson, 347580; 1/200 for IdU labelling) diluted
in blocking buffer (1% BSA in 0.1% Tween-20 -PBS) for
1.5 h at 37◦C. After incubation with primary antibodies, fi-
bre spreads were fixed with 4% PFA-PBS for 10 min at RT
and finally incubated with secondary antibodies (Alexa488-
conjugated anti-rat and Alexa555-conjugated anti-mouse;
1/500) for 1.5 h at 37◦C. Images were obtained using Le-
ica TCS-SL confocal microscopy with a 63× oil immersion
objective and then analysed using Fiji software.
Stalled forks (only-green tracks), restarted forks
(green+red tracks with a maximum gap of 2 m between
them) and new origins (only-red tracks) were quantified.
The number of fibres analysed in each experiment is
indicated in the corresponding figure legend.
RESULTS
Replication resumption is compromised in non-transformed
human cells after severe replication stress
Given the importance of the fidelity of DNA replication
for maintaining genomic stability and preventing tumour
formation, we aimed to analyse the determinants of the re-
sponse to replication stress in non-transformed human cells.
To this end, mitotic entry was evaluated in asynchronously
growing cells treated with the ribonucleotide reductase in-
hibitor HU (24 h) and checkpoint kinases inhibitors (added
during the last 6 h). In agreement with our previous data
(58,62), while inhibition of Chk1 kinase induced a high per-
centage ofHeLa andHCT116 tumour cells to enter intomi-
tosis with a DNA content below 4n, only a small subset of
S-phase arrested cells were shown to enter into mitosis with
unreplicated DNA, even after simultaneous Chk1 and p38
kinases inhibition, in all analysed non-transformed human
cells (Supplementary Figure S1A and B). Similar results
were obtained when HU and checkpoint kinases inhibitors
were added simultaneously to S-phase synchronized non-
transformed human hTERT-immortalized retinal pigment
epithelial (hTERT-RPE) cells (Supplementary Figure S1C).
We next wondered if the observed cell cycle arrest in
non-transformed human cells was reversible. To specif-
ically study the response in S-phase, hTERT-RPE cells
were pulse-labelled with bromodeoxyuridine (BrdU) before
DNA synthesis was inhibited with 10 mM HU, which was
shown to be the minimal dose that induced complete inhi-
bition of DNA synthesis in our hands (Supplementary Fig-
ure S2A). Cell cycle resumption was determined by the abil-
ity of S-phase cells to restart DNA replication and to enter
into mitosis after release from HU treatment in fresh me-
dia containing nocodazole (Figure 1A). Both control and
briefly arrested S-phase cells were able to complete repli-
cation and enter into mitosis during the following 24 h. In
contrast, prolonged treatment with HU prevented mitotic
entry in 80% of the cells. Strikingly, half of the S-phase
treated populationwas arrested with unreplicatedDNA, in-
dicating that not only mitotic entry but also replication re-
sumption was compromised (Figure 1B and C). Similar re-
sults were obtained in another two non-transformed human
cell lines, BJ-5ta (fibroblasts) and MCF10A (mammary ep-
ithelial cells) (Supplementary Figure S2B). Moreover, the
same phenotype could be recapitulated after DNA damage
induced by camptothecin (topoisomerase I inhibitor) and
etoposide (topoisomerase II inhibitor) (Figure 1D), sug-
gesting that severe replication stress, even the one induced
byDSBs in S-phase, causes loss of replication recovery com-
petence in non-transformed human cells.
We next evaluated the long-term effect of a prolonged
replication stress on cell cycle proliferation in hTERT-RPE
cells. Interestingly, proliferation was impaired even 3 days
after release from a 14-h HU treatment (Figure 2A). In
agreement with the induction of permanent arrest in S-
phase, several markers of senescence were observed in cells
that had suffered prolonged replication stress, including -
galactosidase activity, p21 induction and hypophosphory-
lation of Retinoblastoma protein (pRb) (Figure 2B and C).
Loss of replication recovery competence in response to pro-
longed DNA replication inhibition is APC/CCdh1 dependent
In response to DNA synthesis blockade, DNA replication
and mitotic entry are prevented by inhibition of Cyclin A-
andCyclin B-associatedCdk activities, respectively (18–22).
Therefore, we studied Cyclin A2 and Cyclin B1 levels in
 at U
niversitat D
e Barcelona on M
arch 14, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
6 Nucleic Acids Research, 2016
Figure 1. Replication resumption is compromised in non-transformed human cells after severe replication stress. (A) Schematic representation of the proto-
col used in (B) and (C) to analyse S-phase arrest and accumulative mitotic entry in hTERT-RPE cells after DNA replication inhibition. (B) Representative
DNA profiles (PI: propidium iodide) and percentages of mitotic entry (analysed by MPM2 staining) are shown in the graphs. (C) The average percent-
ages of BrdU positive cells that remain in S-phase (left panel) or that enter into mitosis (right panel) after release are shown in the graphs (n = 6). (D)
hTERT-RPE cells were labelled during 30 min with BrdU before treating them during 14 h with camptothecin (CPT, 0.5 M), etoposide (Etop., 50 M)
or left untreated (control). After the treatment, cells were released into fresh media with nocodazole during 24 h. DNA content and mitotic entry of BrdU
positive population was analysed as in (B). The average percentages of cells that remain in S-phase (left panel) and mitosis (right panel) after release from
BrdU positive population are shown in the graphs (n = 3). Means and standard deviation (bars) are shown. Values marked with asterisks are significantly
different (paired t-test, ** P < 0.01, *** P < 0.001).
our experimental conditions. To this end, hTERT-RPE cells
were synchronized in S-phase and either left untreated or
treatedwithHU in the presence of nocodazole. As expected,
unperturbed S-phase synchronized cells accumulated both
cyclins as they progressed into G2 and entered into mitosis.
In contrast, accumulation of Cyclin B1 was slower in HU-
treated cells, as previously described (63). Surprisingly, after
prolongedDNA synthesis inhibition byHUbothCyclinA2
and Cyclin B1 protein levels started to decrease although
cells were still arrested in S-phase (Figure 3A and Supple-
mentaryFigure S2A). This decreasewas due to proteasomal
degradation as the addition of MG132 during the last 6 h
of HU treatment restored their levels (Figure 3B). This was
also observed when cells were synchronized by serum star-
vation and after damage induction in S-phase by different
agents (Supplementary Figure S3A and B). Importantly,
the same phenotype was observed in two additional non-
transformed human cell lines, BJ-5ta and MCF10A (Sup-
plementary Figure S3C).
Cyclin A2 and Cyclin B1 are substrates of the APC/C
ubiquitin ligase (47), which, in complex with its regulatory
subunit Cdh1, has been implicated in the DNA damage
checkpoint response in G2 (44–46). We then hypothesized
that this E3-Ubiquitin ligase could be activated in S-phase
after severe replication stress. Addition of the APC/C in-
hibitor proTAME (64) during HU treatment restored Cy-
clin A2 and Cyclin B1 levels, proving the role of APC/C
in this process (Figure 3C). Moreover, Cdh1 depletion pre-
vented Cyclin A2 and Cyclin B1 degradation after a sus-
tained HU treatment (Figure 3D and Supplementary Fig-
ure S3D). Notice that in this case cells were synchronized in
S-phase before Cdh1 depletion was evident, thus preventing
DNAdamage due toCdh1 knockdown by itself (65–67). In-
terestingly, APC/CCdh1 activity was not specifically directed
to the two cyclins, as more of its substrates, such as Plk1
and Aurora A kinases, were also degraded after prolonged
HU treatment (Supplementary Figure S3E). Moreover, Cy-
clinA2 andCyclin B1 levels were considerably restored after
Cdh1 depletion also in camptothecin- or etoposide-treated
cells (Supplementary Figure S3F) altogether indicating that
APC/CCdh1 is activated in S-phase upon severe replication
stress.
We noticed that APC/CCdh1 activation, measured by Cy-
clin A2 and Cyclin B1 degradation, started ∼12 h after HU
addition, and that this timing correlated with the loss of
replication recovery competence (Figure 3E). It should be
taken into account that thymidine synchronization had no
effect on replication restart (Figures 1 and 3E). In addition,
Cyclin A2 and Cyclin B1 were still degraded following re-
lease from HU treatment, suggesting that APC/CCdh1 ac-
tivity was maintained even when replication stress was re-
moved and could be responsible for impaired resumption
of the cell cycle (Figure 3F). We then predicted that in-
hibition of its activity could overcome the loss of replica-
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Figure 2. hTERT-RPE cells become senescent after prolongedDNA repli-
cation inhibition. (A) S-phase synchronized (by single thymidine block)
hTERT-RPE cells were treated during 14 h with HU or left untreated (Cs)
and then released into fresh media. Cells were harvested at the indicated
time after the treatment and stained with crystal violet (595) to analyse
cell proliferation. The average fold increase relative to control in each time
point is shown in the graphs (n = 4). (B, C) hTERT-RPE cells were syn-
chronized in S-phase, treated during 14 h with HU or left untreated (C:
control) and then harvested (for western blot) or released (R) into fresh
media during 24 h (for western blot) or 48 h (for SA--Gal analysis). Rep-
resentative images of SA--Gal staining (B, left panel), the average fold in-
crease in SA--Gal positive cells relative to control (B, right panel) (n= 4),
and whole cell lysate immunoblots (C) are shown. The arrow indicates the
hyperphosphorylated band of pRb (Retinoblastoma protein). Cdk4 was
used as loading control. Means and standard deviation (bars) are shown.
Values marked with asterisks are significantly different (unpaired t-test, *P
< 0.05, **P < 0.01).
tion recovery after prolonged HU treatment. In agreement
with this, Cdh1 depletion significantly rescued DNA syn-
thesis after sustained DNA replication inhibition (Figure
3G and Supplementary Figure S3G). Thus, APC/CCdh1 ac-
tivity prevents DNA replication recovery after severe repli-
cation stress.
APC/CCdh1 activation in S-phase upon prolonged HU treat-
ment is independent of ATR/ATM activity, but abrogated in
the absence of p53 and p21
To understand the mechanism of APC/CCdh1 activation in
S-phase after severe replication stress, we first analysed the
contribution of ATR and ATM, the main regulators of the
intra-S-phase checkpoint response, to this process. Pharma-
cological inhibition of ATR and ATM, alone or in com-
bination (with VE 821 and KU-55933, respectively), did
not prevent APC/CCdh1 activation in response to prolonged
replication stress, as proteasome inhibition rescued Cyclin
A2 and Cyclin B1 levels in all conditions (Figure 4A, B and
Supplementary Figure S4A). However, while ATR inhibi-
tion alone resulted in advanced cyclins degradation, ATM
inhibition did not modify Cyclin A2 and Cyclin B1 degra-
dation dynamics. In agreement with that, Chk1 inhibition
(with CHIR-124) also caused early APC/CCdh1 activation
in response to HU (Supplementary Figure S4B). In this
sense, APC/CCdh1 activation in response to prolonged HU
treatment correlated with a decrease in Chk1 activity (as
measured by its autophosphorylation at S296 (68)) (Supple-
mentary Figure S4C). Collectively, these data indicate that
ATR and ATM are not essential for APC/CCdh1 activation
after prolonged replication stress, although they may mod-
ify its activation kinetics. In this regard, and consistent with
APC/CCdh1 activity being essential for the loss of replica-
tion recovery competence, inhibition of these kinases could
not restore DNA replication upon release from HU treat-
ment (Supplementary Figure S4D).
It has been reported that the presence of Emi1 is impor-
tant for keeping APC/CCdh1 inhibited during S- and G2-
phases (69). Accordingly, its transcription, which is driven
by E2F, starts at the G1/S transition and Emi1 levels ac-
cumulate until it is degraded at the beginning of mito-
sis (70,71). In this sense, we wondered whether Emi1 was
downregulated after severe replication stress. Indeed, Emi1
levels decreased upon HU treatment, correlating with the
timing of APC/CCdh1 activation (Figure 4C).
After DNA damage, p21 reduces Emi1 expression
through the regulation of pRb phosphorylation, promot-
ing APC/CCdh1 activation inG2 (55). Additionally, p53, the
upstream regulator of p21, has also been implicated in this
function (46). Thus, we analysed the contribution of p53
and p21 to APC/CCdh1 activation in S-phase after replica-
tion stress. Prolonged HU treatment induced an increase in
p53 levels similar to what is observed after camptothecin or
etoposide treatment, whereas no induction of p21 was ob-
served under the same conditions (Supplementary Figure
S4E). However, silencing of p53 or p21 prevented Cyclin
B1 degradation upon severe replication stress (Figure 4D
and E) and, in agreement with our previous results, pro-
moted replication recovery after HU removal (Figure 4F
and G). Consistent with Emi1 being the determining factor
for APC/CCdh1 activity in our conditions, p53 or p21 deple-
tion induced an increase in pRbhyperphosphorylation both
during a normal and a perturbed S-phase that, as expected,
correlated with an increase in Emi1 levels (Figure 4D, E and
H). Nevertheless, even in the absence of p53 or p21, Emi1
was degraded in response to a prolonged HU treatment as
MG132 treatment restored its levels (Figure 4D and E).
Together, these results suggest that Emi1 degradation is
the critical event for APC/CCdh1 activation. In addition,
p53- or p21-deficient cells may become more resistant to
the activation of this ubiquitin ligase upon prolonged DNA
replication stress due to the presence of higher Emi1 levels,
although these proteins are unlikely the molecular determi-
nants of this process.
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Figure 3. Loss of DNA replication recovery competence in response to prolonged replication inhibition is APC/CCdh1- dependent. (A, B, C) hTERT-
RPE cells were synchronized in S-phase by single thymidine block and then treated during the indicated time with HU or left untreated (-). Whole cell
extracts were analysed by western blot with the indicated antibodies. (D) Non-target (NT) or Cdh1 siRNA were transfected to hTERT-RPE cells before
S-phase synchronization by single thymidine block. Cells were then treated with HU during the indicated time. Whole cell extracts were prepared and
analysed by western blot with the indicated antibodies. (E) S-phase synchronized hTERT-RPE cells were treated during the indicated time with HU or
left untreated (Cs) and then harvested for western blot or released into fresh media with nocodazole during 24 h. DNA content was used to determine
the number of cells that remain in S-phase after release (upper panel) (n = 4). Whole cell extracts were prepared and analysed by western blot with the
indicated antibodies (bottom panel). Means and standard deviation (bars) are shown. Values marked with asterisks are significantly different (paired t-test,
**P < 0.01, ****P < 0.0001). (F) S-phase synchronized hTERT-RPE cells were treated during 14 h with HU and then harvested or released into fresh
media during the indicated time. Whole cell extracts were prepared and analysed by western blot with the indicated antibodies. (G) hTERT-RPE cells were
transfected with the indicated siRNA and then synchronized in S-phase. Whole cell lysates of S-phase synchronized untreated cells were harvested for
western blot analysis with the indicated antibodies (right panel). S-phase synchronized cells were treated during 14 h with HU and then released (R) into
fresh media with nocodazole during 24 h. DNA content (PI: propidium iodide) was analysed by flow cytometry to quantify the number of cells that remain
arrested in S-phase after release. Representative DNA profiles (left panel) and the average fold increase of S-phase arrested cells in Cdh1-depleted relative
to non-target siRNA transfected cells are shown in the graph (middle panel) (n = 5). Means and standard deviation (bars) are shown. Values marked with
asterisks are significantly different (unpaired t-test, ***P < 0.001). Where indicated, nocodazole (noc), proTAME and MG132 (MG, added during the
last 6 h of treatment) were added. Cyc: cyclin. GAP120 and Cdk4 were used as loading control.
Lack of APC/CCdh1 activation after prolonged replication in-
hibition increases genomic instability
Our results showing that APC/CCdh1 was activated in S-
phase preventing the resumption of replication after severe
replication stress, prompted us to analyse the consequences
on genomic instability of cell cycle resumption under this
condition. Interestingly, DNA breakage analysis by pulse
field gel electrophoresis (PFGE) and  -H2AX/53BP1 foci
presence indicated that replication forks were being pro-
cessed into DSBs in response to severe replication stress
(Figure 5A and Supplementary Figure S5A). Moreover,
53BP1 foci were still detected 12 h afterHU removal (Figure
5B). Abrogation of APC/CCdh1 activation by p21 or Cdh1
depletion did not significantly affect the amount of cells pre-
senting 53BP1 foci under these conditions. However, our
previous results showed that while non-target siRNA trans-
fected cells were arrested in S-phase, Cdh1 depletion al-
lowed complete DNA duplication (Figure 3G and Supple-
mentary Figure S3G), indicating that these cells progress
to G2 with damaged DNA. In this sense, although silenc-
ing of Cdh1 slightly increased mitotic entry, the majority of
cells remained arrested in G2-phase (Figure 5C and Sup-
plementary Figure S5B). This suggests that damage caused
by prolonged replication stress can be sensed by the G2
checkpoint, and that APC/CCdh1 inactivation alone can-
not overcome this response. Accordingly, silencing of p53
or p21 substantially increased mitotic entry after HU re-
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Figure 4. APC/CCdh1 activation in S-phase after prolonged HU treatment is independent of ATR/ATM activity, but abrogated in the absence of p53 and
p21. (A, B) hTERT-RPE cells were synchronized in S-phase by single thymidine block and treated with HU +/- ATR (VE 821 (ATRi)) and ATM (KU-
55933 (ATMi)) inhibitors alone (A) or in combination (B) during the indicated time. Whole cell lysates were analysed by western blot with the indicated
antibodies. (C) hTERT-RPE cells were synchronized in S-phase and then treated with HU during the indicated time or left untreated. Whole cell lysates
were analysed by western blot with the indicated antibodies. (D, E) hTERT-RPE cells were transfected with the indicated siRNA (NT: non-target) and
synchronized in S-phase by single thymidine block. Cells were then treated with HU for the indicated time. Whole cell lysates were analysed by western blot
with the indicated antibodies. (F, G) hTERT-RPE cells were transfected and synchronized as in (D, E) and then treated during 14 h withHU. Cells were then
released (R) into fresh media with nocodazole during 24 h. DNA content (PI: propidium iodide) was analysed by flow cytometry to quantify the percentage
of cells that remain arrested in S-phase after release. Representative DNA profiles (right panel) and the average fold increase of S-phase arrested cells in
p21-/p53-depleted cells relative to non-target siRNA transfected cells (left panel) are shown in the graphs (n = 4). Means and standard deviation (bars)
are shown. Values marked with asterisks are significantly different (unpaired t-test, ***P < 0.001, ****P < 0.0001). (H) Whole cell lysates of transfected
S-phase synchronized untreated cells were harvested for western blot analysis with the indicated antibodies. Arrows indicate the hyperphosphorylated band
of pRb (Retinoblastoma protein). The asterisk indicates a non-specific band. Where indicated, proteasome inhibitor MG132 (MG) was added during the
last 6 h of treatment. Cs: S-phase synchronized untreated cells. Cyc: cyclin. GAP120, Lamin B and actin were used as loading control. l.e.: long exposure.
s.e.; short exposure.
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moval (Figure 5C). Additionally, p53 or p21 depletion re-
sulted in strong abrogation of senescence, while the fate of
Cdh1-depleted cells did not change (Supplementary Fig-
ure S5C). Remarkably, in all cases, those cells that escaped
G2/M arrest and entered into mitosis were positive for the
DNA damage marker  -H2AX (Figure 5D), highlighting
the importance of inhibition of cell cycle resumption after
severe replication stress. Moreover, in the absence of p21,
where mitotic entry was strongly restored (Figure 5C), G1
cells (Cyclin D1 positive) with 53BP1 foci and cells with mi-
cronuclei were observed after release from HU (Figure 5E).
Thus, inhibition of replication resumption by APC/CCdh1
activation in S-phase might be important to prevent ge-
nomic instability by adding a barrier prior to the G2/M re-
sponse.
To further study the contribution of APC/CCdh1 activa-
tion towards safeguarding genome integrity, we aimed to
analyse the effect of replication inhibition on genomic in-
stability in cells that, in contrast to hTERT-RPE, do not ac-
tivate APC/CCdh1 upon severe replication stress. As tumour
cells usually present a less robust replication checkpoint re-
sponse (58,62), activation of this ubiquitin ligase was first
determined in a panel of nine tumour cell lines. Interest-
ingly, from those, only one (MCF7) activated APC/CCdh1
(as measured by Cyclin A2 and Cyclin B1 degradation),
indicating that tumour cell lines are predominantly defi-
cient inAPC/CCdh1 activation in S-phase in response toHU
(Supplementary Figure S6A). In agreement with our previ-
ous results, this lack of APC/CCdh1 activity strongly cor-
related with the ability to restore DNA synthesis after se-
vere replication stress, as six out of these eight lines were
able to reinitiate DNA replication when released from pro-
longedHU treatment (Supplementary Figure S6B). Among
themwe choseHCT116 cells to study the role ofAPC/CCdh1
in maintaining genomic integrity upon severe replication
stress. First, we validated that a high percentage of HCT116
cells were able to completely resume cell cycle once released
from prolonged HU treatment, as indicated by their ca-
pacity to enter into mitosis and form colonies (Supplemen-
tary Figure S6C and D). Interestingly, a high proportion of
HCT116 cells that reentered the cell cycle under these condi-
tions acquiredDNAdamage and chromosome instability as
measured by the increase in the percentage of G1 cells with
53BP1 foci and the percentage of cells presenting micronu-
clei (Figure 5F and G). To analyse if the acquisition of this
instability might be abrogated by APC/CCdh1 activation in
S-phase, Emi1 was depleted in synchronized HCT116 cells.
As expected, Emi1 depletion during S-phase allowed the
cells to activate APC/CCdh1 (Supplementary Figure S6E).
In agreement with our results, resumption of DNA repli-
cation after prolonged HU treatment was compromised in
Emi1-depleted cells (Supplementary Figure S6F), and con-
sequently, the percentage of cells with 53BP1 foci in G1
decreased (Figure 5H). Likewise, a reduction in the num-
ber of cells presenting micronuclei was also observed un-
der these conditions (Figure 5I). Collectively, these data fur-
ther support the idea that APC/CCdh1 activation in S-phase
in response to severe replication stress may act as an addi-
tional barrier to prevent cell cycle progression with dam-
aged DNA, consequently contributing to safeguarding the
genome integrity.
APC/CCdh1 activation in S-phase in response to severe repli-
cation stress inhibits new origin firing
As shown above, hTERT-RPE cells are able to reinitiate S-
phase after a 2-h HU treatment while this recovery is abol-
ished after a 14-h HU treatment, when replication forks
are being processed into DSBs and APC/CCdh1 is activated
(Figures 1, 3E, 5A and Supplementary Figure S5A). Re-
sumption of replication in the presence ofDSBs has been re-
ported to involve either HR mechanisms, which depend on
the presence of Rad51-coated 3′ ssDNA ends, or new origin
firing (26,27,72–74). To analyse whether any of these mech-
anisms are inhibited by APC/CCdh1 activation in S-phase,
we first decided to better characterize the loss of replication
recovery competence in hTERT-RPE cells. To this end, we
monitored replication by single molecule DNA fibre analy-
sis after a 2- or 14-hHU treatment. Cells were pulse-labelled
with 5-chlorodeoxyuridine (CldU) for 30 min, followed by
2 h or 14 h of exposure to HU, and labelled again for a
period of 60 min with 5-iododeoxyuridine (IdU). The sec-
ond labelling period was extended to avoid any interference
from a possible delay in restarting stalled forks in the anal-
ysis. Additionally, as a slight replication fork progression
was observed during the first 15 min of HU treatment (Sup-
plementary Figure S7A), we decided to maintain the CldU
in the media during this time to avoid progression of the
forks without CldU incorporation. The analysis of IdU in-
corporation during the rest of HU treatment confirmed that
replication was completely blocked after these 15 min (Sup-
plementary Figure S7A). As shown in Figure 6A, after 2
h HU almost all forks were able to restart DNA synthe-
sis (the same proportion as untreated cells), whereas half
of the active replication forks were stalled upon 14 h of HU
treatment. Interestingly, lack of replication fork restart was
not compensated by an increment in new origin firing, sug-
gesting that this pathway was inhibited under these con-
ditions. Moreover, the absence of gaps between green and
red tracks at restarted forks confirmed that replication forks
were completely blocked in the presence ofHU, and allowed
us to confidently quantify the number of new origins (only-
red/ IdU tracks) in each condition.
To further analyse how replication fork restart is lost af-
ter prolonged DNA replication inhibition, we monitored
Rad51 association with chromatin and replication forks (by
iPOND) after short and long HU treatments. Rad51 was
present in chromatin and replication forks during unper-
turbed S-phase and its association increased after a short
(2 h) HU treatment as previously described (26,75). In con-
trast, Rad51 disassembled from both chromatin and repli-
cation forks after prolonged inhibition of DNA synthe-
sis, when DSBs were already present (Figures 6B, C, 5A
and Supplementary Figure S5A) and was not reestablished
even after release from HU (Figure 6B), suggesting that
Rad51-dependent replication fork restart was impaired af-
ter prolonged, but not short, HU treatment in hTERT-
RPE cells. In agreement with the already known role of
Rad51 in protecting ssDNA (75–77), and with the fact
that it was dissociated from replication forks after a 14-h
HU treatment, CldU-labelled tracks were shorter after pro-
longed HU treatment, suggesting that DNA was degraded
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Figure 5. Lack of APC/CCdh1 activity after severe replication stress correlates with an increase in genomic instability. (A) Single thymidine block syn-
chronized S-phase hTERT-RPE cells were treated during the indicated time with HU or left untreated (control), and then harvested for DNA breakage
analysis by PFGE. Cells treated during 14 h with camptothecin (CPT, 0.5 M) were used as positive control. A representative image from three indepen-
dent experiments is shown. (B) siRNA transfected and S-phase synchronized (by single thymidine block) hTERT-RPE cells were treated with HU during
14 h or left untreated (Cs), and then released (R) into fresh media during 12 h. Cells were fixed and immunostained with 53BP1 antibody. The average
percentage of cells with 53BP1 foci (>6 foci) from total population are shown (n= 4). Means and standard deviation (bars) are shown. Values marked with
asterisks are significantly different (paired t-test, *P < 0.05, **P < 0.01). (C) siRNA transfected and S-phase synchronized (as in Figures 3G, 4F and G)
hTERT-RPE cells were treated with HU during 14 h and released into fresh media with nocodazole during 24 h. The number of mitosis (MPM2 positive
cells) was quantified by flow cytometry. The average fold increase of mitotic cells in Cdh1-/p21-/p53-depleted cells relative to non-target (NT) siRNA
transfected cells is shown in the graph (n = 4). Means and standard deviation (bars) are shown. Values marked with asterisks are significantly different
(unpaired t-test, *P < 0.05, **P < 0.01). (D) hTERT-RPE cells were transfected and synchronized as in (B). S-phase synchronized cells were treated with
HU during 14 h and then released into fresh media with nocodazole during 24 h before fixing and immunostaining themwith  -H2AX antibody. DNAwas
counterstained with propidium iodide. Representative images are shown. (E) siRNA transfected and S-phase synchronized hTERT-RPE cells were treated
during 14 h with HU, and then released into fresh media during 12 h. Finally, cells were fixed and immunostained with 53BP1 and Cyclin D1 (CycD1)
antibodies (left panel). Cells were counterstained with DAPI to analyse the presence of micronuclei (upper-right panel). Untreated S-phase synchronized
cells were harvested and whole cell lysates were prepared to analyse them by western blot with the indicated antibodies (bottom-right panel). Cdk4 was
used as loading control. (F, G) HCT116 cells were synchronized in S-phase by single thymidine block before treating them with HU during 14 h or left
untreated. Cells were then released into fresh media during 12 h after which cells were fixed and immunostained with 53BP1 and Cyclin D1 antibodies.
Representative images (F, upper panel) and the average percentage of cells with 53BP1 foci from G1 (Cyclin D1 positive) population (F, bottom panel)
are shown (n = 3). DNA was counterstained with DAPI to analyse the presence of micronuclei. A representative image (G, upper panel) and the average
percentage of cells with micronuclei (G, bottom panel) are shown (n = 3). Means and standard deviation (bars) are shown. Values marked with asterisks
are significantly different (paired t-test *P < 0.05). (H, I) HCT116 cells were transfected with the indicated siRNA and 4 h later thymidine was added to
synchronize cells in S-phase. After synchronization, cells were treated with HU and immunostained for 53BP1 and Cyclin D1 analysis as in (F, G). The
average percentage of cells with 53BP1 foci in G1 (H) and the average percentage of cells with micronuclei (I) are shown (n = 3). Means and standard
deviation (bars) are shown. Values marked with asterisks are significantly different (unpaired t-test, *P < 0.05, **P < 0.01).
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Figure 6. Replication forks of hTERT-RPE cells become inactivated after prolonged DNA replication inhibition. (A) Labelling protocol for DNA fibre
analysis (upper panel). S-phase synchronized (by single thymidine block) hTERT-RPE cells were treated as indicated and then DNA fibres were prepared
and labelled with anti-BrdU antibodies. The percentage of replication fork restart, stalled replication forks and new origin firing relative to total CldU
labelled fibres are shown in the graphs. At least 1500 fibres from three independent experiments were counted in each condition. Means and standard
deviation (bars) are shown. Values marked with asterisks are significantly different (paired t-test, *P < 0.05). Representative images of each condition
are shown (right panel). (B) S-phase synchronized hTERT-RPE cells were treated during the indicated time with HU or left untreated (Cs). Cells were
harvested just after the treatment or after a 30 min release into fresh media (14 h HU + R). Chromatin extracts were prepared and analysed by western
blot with the indicated antibodies. Input: whole cell lysates. Lamin B was used as loading control. (C) hTERT-RPE cells were synchronized in S-phase
and labelled with EdU during 15 min before treating them with HU during the indicated time. EdU was present in the media for additional 15 min in
HU-treated cells. Isolated proteins on nascent DNA (iPOND) were analysed by western blot with the indicated antibodies. Input: nuclear extracts. Pulse:
cells were harvested just after EdU labelling. Chase: 15 min EdU + 2 h thymidine (50 M) chase. (-): no EdU. (D) DNA fibres from (A) were used to
measure the CldU track length. Three hundred fibres were counted in each condition. CldU track length distribution and statistical analysis of CldU track
distribution are shown. Box and whiskers show Min, Max, Median and first quartiles. Values marked with asterisks are significantly different (unpaired
t-test, n.s.: non-statistically significant, ****P < 0.0001).
at stalled replication forks after sustained replication stress
(Figure 6D).
To determine how Cdh1 depletion led to the recovery
of DNA replication, and consequently discern the function
of APC/CCdh1 in S-phase in response to severe replication
stress, we first analysed the association of Rad51 with chro-
matin after Cdh1 depletion. As shown in Figure 7A, Cdh1
knockdown did not rescueRad51 levels in chromatin after a
14-hHU treatment. Consistent with this, CldU track length
shortening was also observed at stalled but not restarted
forks of Cdh1-depleted cells (Figure 7B and Supplemen-
tary Figure S7B). Likewise, DNA fibre analysis showed
that the percentage of restarted forks did not increase af-
ter Cdh1 depletion (Figure 7C and D), altogether indicat-
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Figure 7. APC/CCdh1 inhibits new origin firing in S-phase after prolonged HU treatment. (A) Non-target (NT) or Cdh1 siRNA were transfected to
hTERT-RPE cells before synchronizing them in S-phase by single thymidine block. Cells were then treated with HU (or left untreated (Cs)) during the
indicated time. Chromatin extracts were prepared and analysed by western blot with the indicated antibodies. Input: whole cell lysates. Lamin B was used
as loading control. (B, C, D) Schematic of the labelling protocol (B, upper-right panel). hTERT-RPE cells were transfected with the indicated siRNA
and synchronized in S-phase before CldU (250 M) labelling. Whole cell lysates of S-phase synchronized untreated cells were harvested for western blot
analysis with the indicated antibodies (B, upper-left panel). Cdk4 was used as loading control. CldU track length of 300 fibres from three independent
experiments was measured. CldU track length distribution and statistical analysis are shown (B, bottom panel). Box and whiskers showMin,Max,Median
and first quartiles. Values marked with asterisks are significantly different (unpaired t-test, n.s.: non-statistically significant, ****P< 0.001). The percentage
of replication fork restart, stalled replication forks and new origin firing relative to total CldU labelled fibres is shown in the graphs (C). More than 1000
fibres from three independent experiments were counted in each condition. Means and standard deviation (bars) are shown. Values marked with asterisks
are significantly different (paired t-test, n.s.: non-statistically significant, *P < 0.05, **P < 0.01). Representative images of each condition are shown (D).
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ing that Rad51-dependent HR is not the mechanism used
by Cdh1-depleted hTERT-RPE cells to resume S-phase af-
ter prolonged HU treatment. We then wondered whether
the role of APC/CCdh1 in S-phase is to inhibit new origin
firing after prolonged replication stress. As expected, the
percentage of stalled forks remained unchanged while an
increase in the number of new origin firing events was ob-
served inCdh1-depleted cells compared to non-target trans-
fected ones (Figure 7C andD). Furthermore, the percentage
of active forks (restart + new origin) after a 14-h HU treat-
ment relative to initial ones (all CldU labelled forks) was
∼80% in Cdh1-depleted cells, indicating that the observed
increase in new origin firing might be sufficient to restore
DNA synthesis after prolonged inhibition of replication in
these cells (Figure 7C and D). Accordingly, in the absence
of Cdh1, the IdU incorporation rate (measured by the aver-
age IdU intensity per nucleus) was similar in S-phase cells
treated for a short and a longer time (Supplementary Fig-
ure S7C), which supports the idea that the new origin firing
observed in the absence of APC/CCdh1 activation is suffi-
cient to reestablish the DNA replication rate. It should be
considered that with themethodology used, firing of nearby
dormant origins (78) cannot be distinguished from real fork
restart and thus, the observed new firing events may corre-
spond mainly to those activated in different replicons.
Altogether, our results show that APC/CCdh1 is activated
in S-phase after prolonged HU treatment, preventing new
origin firing in hTERT-RPE cells and thus contributing to
the inhibition of replication resumption after severe repli-
cation stress.
DISCUSSION
Recovery from mild replication stress can be achieved with
a low risk of introducing changes into the genome, whereas
after severe replication stress that induces fork collapse,
reinitiation of DNA replication may promote genomic al-
terations and epigenetic changes (28,30,33–37,72). Thus, al-
though recovery from severe replication stressmight be ben-
eficial for unicellular organisms, as it will allow further pro-
liferation, it would not be advantageous for multicellular
organisms. In this sense, based on studies mainly done in
tumour cells, it has been proposed that under these circum-
stances reinitiation of DNA replication occurs simply to al-
low cells to arrive at G2, where DNA damage is expected to
be repaired, and if this fails, cells will be driven to apopto-
sis or senescence (79). Data presented here show that after
prolonged DNA replication inhibition that induces DSBs
in S-phase, non-transformed human cells are not compe-
tent to resume DNA replication and progress into G2 due
to APC/CCdh1 activation, which leads to a permanent cell
cycle exit from S-phase. Activation of APC/CCdh1 during
G2 as a long-term response to genotoxic agents has been
described (45,46,55), but to our knowledge, this is the first
work showing APC/CCdh1 activation during S-phase in re-
sponse to severe replication stress.
In agreement with previous data from tumour cells,
hTERT-RPE cells reinitiate DNA synthesis by fork restart
following a short HU treatment, while after prolonged HU
treatment, which leads to DSBs accumulation, fork restart
is strongly abrogated (26). Strikingly, whereas in tumour
cells new origin firing allows reactivation of replication af-
ter prolonged HU treatment, we show here that origin fir-
ing is inhibited in hTERT-RPE cells, and consequently,
the resumption of DNA replication upon HU removal is
strongly compromised. Interestingly, our data indicates that
APC/CCdh1 activation in S-phase after severe replication
arrest is the responsible for inhibition of new origin fir-
ing during recovery. The kinases Cdk2/Cyclin A (80) and
Cdc7/Dbf4 (81) are essential for the induction of origin fir-
ing in S-phase, both regulatory subunits being well-known
APC/CCdh1 substrates (82,83). In this sense, we have shown
that Cyclin A2, together with other APC/CCdh1 substrates,
is degraded after prolonged treatment with HU as well as
upon its removal. Therefore, we propose that the role of
APC/CCdh1 in preventing new origin firing during recovery
is mediated by Cyclin A degradation, although we cannot
exclude that degradation of other substrates, such as Dbf4,
is also implicated.
Rad51 is essential to protect ssDNA and mediate fork
restart at stalled replication forks (72,75–77). Accordingly,
the association of Rad51 with replication forks increased
upon short HU treatment, after which replication was reini-
tiated. However, after prolonged HU treatment Rad51 dis-
sociated from replication forks. Consistent with previous
reports, we found that Rad51 dissociation correlated with
nascent DNA degradation at stalled but not at restarted
forks. Loss of Rad51 would explain the lack of fork restart
under this condition, as both Rad51-mediated fork restart
and BIR-mediated restart may be hindered. After pro-
longed HU treatment, Cdh1 depletion did not restore
Rad51 recruitment to the chromatin, and neither did it have
any effect on nascent DNA degradation, although, consis-
tent with recently published data (84), CtIP nuclease was
degraded by APC/CCdh1 (unpublished observation). Thus,
although we cannot rule out a role for APC/CCdh1 in con-
trolling DNA processing and Rad51 dissociation at stalled
replication forks, we propose that its main function in S-
phase is to inhibit new origin firing and thereby prevent the
only mechanism left to complete DNA replication.
Due to the relevance of APC/CCdh1 in cell cycle progres-
sion, evolution has led to a very tight regulation of its activ-
ity: inhibitory phosphorylation of Cdh1 by Cdk1 and Cdk2
(51,85,86) and inhibition byEmi1 binding, the transcription
of which is regulated by pRb/ E2F (69). Its activation in G2
upon genotoxic stress has been shown to be ATM-, p53-
and p21-dependent (46,55,56). In contrast, we show here
that APC/CCdh1 activation in S-phase is not prevented by
ATR/ATM inhibition. In relation to p53 and p21, although
the lack of these proteins prevents APC/CCdh1 activation
in S-phase, we suggest that this is probably due to the ele-
vated Emi1 levels already present in untreated p53- and p21-
depleted cells. Consistent with this, p21 protein levels were
not upregulated after a 14-h HU treatment, at which point
APC/CCdh1 substrates degradation was readily detected.
Thus, we propose that Emi1 degradation is more likely the
trigger of APC/CCdh1 activation in S-phase. Interestingly, it
has recently been shown that Chk1 can phosphorylate and
inhibit Cdh1 activity after replication stress (82,87). No-
tably, APC/CCdh1 activation by prolonged HU treatment
correlated in time with a decrease in Chk1 phosphorylation.
Thus, it is also conceivable that a decrease in Chk1 activity
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collaborates in the initial trigger of APC/CCdh1 activation.
Consistent with this, ATR or Chk1 inhibition resulted in
advanced APC/CCdh1 activation. Nevertheless, it should be
considered that Chk1 could also have an activating effect on
APC/CCdh1 through Cdc25 inhibition and hence Cdk inac-
tivation.
Additionally, the advanced APC/CCdh1 activation ob-
served upon inhibition of ATR/Chk1 may also be caused
by an increase in the number of DSBs. In this sense,
ATR/Chk1 activation during replication stress prevents
DSB generation, by inhibiting origin firing and Mus81 nu-
clease, among others (14,88). A decrease in Chk1 activity
can occur through different mechanisms, such as Chk1 and
Claspin degradation (89,90). Although we did not specif-
ically analyse the mechanism by which Chk1 is inacti-
vated, we observed a decrease in Chk1 autophosphoryla-
tion mainly after prolonged HU treatment, correlating with
the processing of replication forks into DSBs. Chk1 inacti-
vation in the presence of replication stressmight be an adap-
tive mechanism to allow replication to continue through
late origin firing or BIR-mediated restart. Since such mech-
anisms may induce epigenetic changes and genomic rear-
rangements, and taking into account that APC/CCdh1 acti-
vation correlates in time with Chk1 inactivation, we suggest
that APC/CCdh1 inhibits new origin firing once Chk1 can-
not perform this role.
After prolonged inhibition of replication, Cdh1-depleted
cells duplicated their DNA despite having DNA lesions,
and mostly arrested in G2. These data support recent find-
ings indicating that, althoughAPC/CCdh1 is activated in G2
upon DNA damage, p53 and p21 are sufficient to induce
permanent cell cycle exit from G2 (42,43). Importantly, the
few cells that eventually escape this G2 checkpoint enter
into mitosis with damaged DNA ( -H2AX foci). Further-
more, p21- and p53-depleted cells released from severe repli-
cation stress are able, on the one hand, to reinitiate replica-
tion due to the inability to activate APC/CCdh1 in S-phase,
and on the other hand, to enter into mitosis due to the lack
of a functional G2 checkpoint. Consequently, APC/CCdh1
activation in S-phase may work as an earlier additional
mechanism to the G2 DNA damage checkpoint to avoid
proliferation of cells with damaged or inaccurately repli-
cated DNA.
In addition to the loss of ability to complete DNA du-
plication, we also observed the induction of different senes-
cence markers, such as pRb hypophosphorylation, p21 up-
regulation and SA--Gal activity after prolonged inhibition
ofDNAreplication.However, wewere unable to analyse the
real contribution of APC/CCdh1 to the induction of senes-
cence in S-phase cells in our conditions, as Cdh1-depleted
cells undergo senescence in G2 in a p53 and p21-dependent
manner, and their depletion prevents APC/CCdh1 activation
after severe replication stress. Nevertheless, several lines of
evidence indicate that APC/CCdh1 activation by itself is suf-
ficient to induce senescence (56,91,92). Thus, we suggest
that APC/CCdh1 could reinforce the permanent cell cycle
exit and senescence observed in S-phase.
It is now well accepted that oncogene expression induces
replication stress leading to activation of the DNA damage
response and senescence, which acts as tumourigenic bar-
rier (8,9). Interestingly, our data suggest that APC/CCdh1
is a new element of this barrier. Thus, one should expect
that avoiding APC/CCdh1 activation in S-phase would ben-
efit tumour cells. Consistently, we found that tumour cell
lines are predominantly deficient in APC/CCdh1 activation
in S-phase in response to HU, and that this correlates with
the ability to resume DNA replication after this treatment.
In addition, data from HCT116 cells show that this may al-
low them to resume cell cycle and proliferate whilst bear-
ing damaged DNA, as observed by the presence of 53BP1
foci in the next G1, and in chromosomal abnormalities such
as micronuclei. Our data indicate that p53 inactivation, p21
down-regulation or Emi1 overexpression are, among others,
alterations that may abrogate this novel replication stress
response and consequently favour genomic instability and
tumourigenesis. It has been described that Emi1 inhibition
itself can activate APC/CCdh1 (93,94). Consistent with this
reports, Emi1 depletion in synchronized HCT116 allowed
APC/CCdh1 activation in S-phase. Interestingly, proving a
role of APC/CCdh1 in preventing genomic instability upon
replication stress, this resulted in impaired replication re-
sumption after HU treatment and a decrease in the number
of G1 cells with DSBs and cells with micronuclei.
In conclusion, our work provides evidence of the partic-
ipation of APC/CCdh1 in inducing a permanent cell cycle
exit from S-phase through inhibition of new origin firing
after prolonged DNA replication stress, thereby contribut-
ing to the maintenance of genome integrity. Consequently,
we propose that alterations in this response would be ben-
eficial for tumour progression. Promisingly, and although
further studies are needed, these differences in the response
between non-transformed and tumour cells could provide
an opportunity to develop new therapeutic strategies that
specifically target cancer cells.
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